跳至主要内容
临床试验/NCT05192824
NCT05192824招募中不适用

Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality

Tianjin Eye Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年12月10日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Changes in axial length in 2 years

研究概览

简要总结

This study was aimed to evaluate the effects of different Orthokeratology,including the size of central optical zone and the height of peripheral reverse curve, on myopia control and visual quality.

详细描述

This study was aimed to evaluate the effects of different Orthokeratology on myopia control and visual quality. The different optical zone of Orthokeratology lens was divided into 4 groups, ranged from 5.5 mm to 6 mm. And the control group subjects with the single glasses was included. The effectiveness of Orthokeratology was measured by axial length progression. The visual quality of subjects was evaluated by a questionnaire, contrast sensitivity and wavefront aberration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
8 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Myopia: between -1.00D and 4.00D in both eyes
  • Astigmatism: <1.5D for with-the-rule astigmatism, <1.00D for the against-the-rule astigmatism
  • Visual acuity: the best corrected vision acuity(BCVA)≥20/20 in both eyes
  • Subjects that volunteer to participate in the clinical trial and sign informed consent

排除标准

  • Contraindications of wearing Ortho-K.
  • Diagnosis of strabismus, amblyopia and other refractive development of the eye or systemic diseases.
  • Any type of strabismus or amblyopia
  • Systemic condition which might affect refractive development (for example, Down syndrome, Marfan's syndrome)
  • Ocular conditions which might affect the refractive error (for example, cataract, ptosis)

结局指标

主要结局

Changes in axial length in 2 years

时间窗: Every 6 months for a period 2 years

The axial length was measured by AL-scan

Changes in Cycloplegic subjective refraction in 2 years

时间窗: Every 6 months for a period 2 years

The cycloplegic subjective refraction was evaluated by optometrist

次要结局

  • Change in visual questionnaire as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)
  • Change in High-order aberrations (HOAs) in microns as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)
  • Change in contrast sensitivity as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)
  • Change in choroidal thickness captured by Optical Coherent Tomographer (OCT) as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)
  • Change in Corneal epithelial thickness captured by Optical Coherent Tomographer (OCT) as compared to baseline(Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)
  • Change in corneal biomechanics parameters (SSI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)
  • Change in peripheral refraction as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)
  • Change in corneal surface regularity index (SRI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)
  • Change in corneal surface asymmetry index (SAI) as compared to baseline (Postoperative 6 months, 12 months, 18 months and 24 months)(baseline, postoperative 6 months, 12 months, 18 months and 24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shuxian zhang

Director

Tianjin Eye Hospital

研究点 (1)

Loading locations...

相似试验